A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4764-4772

  He, Songqing ^a,b   Atkinson, Carl ^a   Evans, Zachary ^a   Ellett, Justin D ^a   Southwood, Mark ^c   Elvington, Andrew ^a   Chavin, Kenneth D ^a   Tomlinson, Stephen ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; COMPLEMENT COMPONENT C3; COMPLEMENT INHIBITOR; CR2 CRRY COMPLEMENT INHIBITOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG; CR2 CRRY FUSION PROTEIN, MOUSE; CR2-CRRY FUSION PROTEIN, MOUSE; HYBRID PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT COMPONENT C3 DEFICIENCY; COMPLEMENT DEFICIENCY; COMPLEMENT INHIBITION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DONOR; FATTY LIVER; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; INFLAMMATION; LEAN BODY WEIGHT; LIVER ISCHEMIA; LIVER PROTECTION; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL; WILD TYPE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG ANTAGONISM; FAT INTAKE; GRAFT REJECTION; IMMUNOLOGY; LIVER; MOUSE MUTANT; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; COMPLEMENT C3; DIETARY FATS; DISEASE SUSCEPTIBILITY; FATTY LIVER; GRAFT REJECTION; LIVER; LIVER TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT FUSION PROTEINS; REPERFUSION INJURY;

EID: 70449715728     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900550     Document Type: Article

References (49)

1. Chiari, P., V. Piriou, G. Hadour, C. Rodriguez, J. Loufouat, J. J. Lehot, M. Ovize, and R. Ferrera. 2002. Preservation of ischemia and isoflurane-induced preconditioning after brain death in rabbit hearts. Am. J. Physiol. 283: H1769-H1774.
2. Samarasinghe, D., and C. Tasman-Jones. 1992. The clinical associations with hepatic steatosis: a retrospective study. N. Z. Med. J. 105: 57-58.
3. Merritt, W. T. 2005. Issues affecting liver transplantation. Best Pract. Res. Clin. Anaesthesiol. 19: 17-34.
4. Ferraz-Neto, B. H., M. P. Zurstrassen, R. Hidalgo, L. E. Fonseca, T. D. Motta, F. L. Pandullo, M. B. Rezende, S. P. Meira-Filho, J. R. Sa, and R. C. Afonso. 2007. Donor liver dysfunction: application of a new scoring system to identify the marginal donor. Transplant. Proc. 39: 2516-2518.
5. McCormack, L., H. Petrowsky, W. Jochum, B. Mullhaupt, M. Weber, and P. A. Clavien. 2007. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann. Surg. 246: 940-946; discussion 946-948.
6. Birsner, J. H., C. Wan, G. Cheng, Z. P. Evans, C. C. Polito, R. N. Fiorini, G. Gilbert, J. K. Haines, M. G. Schmidt, and K. D. Chavin. 2004. Steatotic liver transplantation in the mouse: a model of primary nonfunction. J. Surg. Res. 120: 97-101.
7. Chavin, K. D., R. N. Fiorini, S. Shafizadeh, G. Cheng, C. Wan, Z. Evans, D. Rodwell, C. Polito, J. K. Haines, G. M. Baillie, and M. G. Schmidt. 2004. Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation. Am. J. Transplant. 4: 1440-1447.
8. Fiorini, R. N., S. F. Shafizadeh, C. Polito, D. W. Rodwell, G. Cheng, Z. Evans, C. Wan, S. Belden, J. K. Haines, J. Birsner, et al. 2004. Anti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice. Am. J. Transplant. 4: 1567-1573.
9. Chavez-Cartaya, R. E., G. P. DeSola, L. Wright, N. V. Jamieson, and D. J. White. 1995. Regulation of the complement cascade by soluble complement receptor type 1: protective effect in experimental liver ischemia and reperfusion. Transplantation 59: 1047-1052.
10. Lehmann, T. G., T. A. Koeppel, S. Munch, M. Heger, M. Kirschfink, E. Klar, and S. Post. 2001. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia. Microvasc. Res. 62: 284-292.
11. Lehmann, T. G., M. Heger, S. Munch, M. Kirschfink, and E. Klar. 2000. In vivo microscopy reveals that complement inhibition by C1-esterase inhibitor reduces ischemia/reperfusion injury in the liver. Transplant. Int. 13(Suppl. 1): S547-S550.
12. Heijnen, B. H., I. H. Straatsburg, N. D. Padilla, G. J. Van Mierlo, C. E. Hack, and T. M. Van Gulik. 2006. Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model. Clin. Exp. Immunol. 143: 15-23.
13. Bergamaschini, L., G. Gobbo, S. Gatti, L. Caccamo, P. Prato, M. Maggioni, P. Braidotti, R. Di Stefano, and L. R. Fassati. 2001. Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver. Clin. Exp. Immunol. 126: 412-420.
14. Inderbitzin, D., G. Beldi, I. Avital, G. Vinci, and D. Candinas. 2004. Local and remote ischemia-reperfusion injury is mitigated in mice overexpressing human C1 inhibitor. Eur. Surg. Res. 36: 142-147.
15. Arumugam, T. V., T. M. Woodruff, S. Z. Stocks, L. M. Proctor, S. Pollitt, I. A. Shiels, R. C. Reid, D. P. Fairlie, and S. M. Taylor. 2004. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats. J. Hepatol. 40: 934-941. (Pubitemid 38670127)
16. Strey, C. W., M. Markiewski, D. Mastellos, R. Tudoran, L. A. Spruce, L. E. Greenbaum, and J. D. Lambris. 2003. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 198: 913-923.
17. Markiewski, M. M., D. Mastellos, R. Tudoran, R. A. DeAngelis, C. W. Strey, S. Franchini, R. A. Wetsel, A. Erdei, and J. D. Lambris. 2004. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J. Immunol. 173: 747-754.
18. Yuceturk, H., M. C. Yagmurdur, G. Gur, M. Demirbilek, B. Bilezikci, M. Turan, H. Karakayali, and M. Haberal. 2007. Role of heparin on TNF-α and IL-6 levels in liver regeneration after partial hepatic resection. Eur. Surg. Res. 39: 216-221. (Pubitemid 47000368)
19. Atkinson, C., H. Song, B. Lu, F. Qiao, T. A. Burns, V. M. Holers, G. C. Tsokos, and S. Tomlinson. 2005. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J. Clin. Invest. 115: 2444-2453.
20. Atkinson, C., H. Zhu, F. Qiao, J. C. Varela, J. Yu, H. Song, M. S. Kindy, and S. Tomlinson. 2006. Complement-dependent P-selectin expression and injury following ischemic stroke. J. Immunol. 177: 7266-7274. (Pubitemid 44715096)
21. Evans, Z. P., J. D. Ellett, M. G. Schmidt, R. G. Schnellmann, and K. D. Chavin. 2008. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J. Biol. Chem. 283: 8573-8579.
22. Theruvath, T. P., C. Czerny, V. K. Ramshesh, Z. Zhong, K. D. Chavin, and J. J. Lemasters. 2008. C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation. Am. J. Transplant. 8: 1819-1828.
23. Neil, D. A., and S. G. Hubscher. 2001. Are parenchymal changes in early posttransplant biopsies related to preservation-reperfusion injury or rejection? Transplantation 71: 1566-1572.
24. Juan, M. E., M. Maijo, and J. M. Planas. 2009. Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. J. Pharm. Biomed. Anal. Epub ahead of print.
25. Fiorini, R. N., J. Kirtz, B. Periyasamy, Z. Evans, J. K. Haines, G. Cheng, C. Polito, D. Rodwell, S. F. Shafizadeh, X. Zhou, et al. 2004. Development of an unbiased method for the estimation of liver steatosis. Clin. Transplant. 18: 700-706.
26. Pritchard, M. T., M. R. McMullen, A. B. Stavitsky, J. I. Cohen, F. Lin, M. E. Medof, and L. E. Nagy. 2007. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132: 1117-1126. (Pubitemid 46440876)
27. -/- mice that do not develop ethanol-induced steatosis. J. Hepatol. 46: 907-914.
28. Bykov, I., S. Junnikkala, M. Pekna, K. O. Lindros, and S. Meri. 2006. Complement C3 contributes to ethanol-induced liver steatosis in mice. Ann. Med. 38: 280-286. (Pubitemid 43862330)
29. Galloway, E., T. Shin, N. Huber, T. Eismann, S. Kuboki, R. Schuster, J. Blanchard, H. R. Wong, and A. B. Lentsch. 2008. Activation of hepatocytes by extracellular heat shock protein 72. Am. J. Physiol. 295: C514-C520.
30. Langdale, L. A., V. Hoagland, W. Benz, K. J. Riehle, J. S. Campbell, D. H. Liggitt, and N. Fausto. 2008. Suppressor of cytokine signaling expression with increasing severity of murine hepatic ischemia-reperfusion injury. J. Hepatol. 49: 198-206.
31. + exchanger inhibitor, and its inhibition of iNOS induction in hepatic ischemia-reperfusion injury in rats. Shock 30: 311-317.
32. Kaizu, T., A. Ikeda, A. Nakao, A. Tsung, H. Toyokawa, S. Ueki, D. A. Geller, and N. Murase. 2008. Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am. J. Physiol. 294: G236-G244.
33. Sacks, S. H., and W. Zhou. 2003. Locally produced complement and its role in renal allograft rejection. Am. J. Transplant. 3: 927-932.
34. Fuller, T. F., B. Sattler, L. Binder, F. Vetterlein, B. Ringe, and T. Lorf. 2001. Reduction of severe ischemia/reperfusion injury in rat kidney grafts by a soluble P-selectin glycoprotein ligand. Transplantation 72: 216-222.
35. Chan, R. K., S. I. Ibrahim, N. Verna, M. Carroll, F. D. Moore, Jr., and H. B. Hechtman. 2003. Ischaemia-reperfusion is an event triggered by immune complexes and complement. Br. J. Surg. 90: 1470-1478.
36. Chan, R. K., N. Verna, J. Afnan, M. Zhang, S. Ibrahim, M. C. Carroll, and F. D. Moore, Jr. 2006. Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM. Surgery 139: 236-243.
37. Riedemann, N. C., and P. A. Ward. 2003. Complement in ischemia reperfusion injury. Am. J. Pathol. 162: 363-367.
38. Zhang, M., W. G. Austen, Jr., I. Chiu, E. M. Alicot, R. Hung, M. Ma, N. Verna, M. Xu, H. B. Hechtman, F. D. Moore, Jr., and M. C. Carroll. 2004. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 101: 3886-3891.
39. El-Badry, A. M., W. Moritz, C. Contaldo, Y. Tian, R. Graf, and P. A. Clavien. 2007. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology 45: 855-863.
40. Selzner, N., M. Selzner, W. Jochum, B. Amann-Vesti, R. Graf, and P. A. Clavien. 2006. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J. Hepatol. 44: 694-701.
41. Paglialunga, S., A. Fisette, Y. Yan, Y. Deshaies, J. F. Brouillette, M. Pekna, and K. Cianflone. 2008. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am. J. Physiol. Endocrinol. Metab. 294: E521-E529.
42. Maslowska, M., H. W. Wang, and K. Cianflone. 2005. Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitam. Horm. 70: 309-332. (Pubitemid 43589024)
43. El-Badry, A. M., R. Graf, and P. A. Clavien. 2007. Omega 3-omega 6: what is right for the liver? J. Hepatol. 47: 718-725.
44. Vetelainen, R., A. van Vliet, D. J. Gouma, and T. M. van Gulik. 2007. Steatosis as a risk factor in liver surgery. Ann. Surg. 245: 20-30. (Pubitemid 46035431)
45. Scoazec, J. Y., G. Borghi-Scoazec, F. Durand, J. Bernuau, B. N. Pham, J. Belghiti, G. Feldmann, and C. Degott. 1997. Complement activation after ischemia-reperfusion in human liver allografts: incidence and pathophysiological relevance. Gastroenterology 112: 908-918.
46. Gregoire, F. M., Q. Zhang, S. J. Smith, C. Tong, D. Ross, H. Lopez, and D. B. West. 2002. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am. J. Physiol. Endocrinol. Metab. 282: E703-E713. (Pubitemid 34654789)
47. Okaya, T., and A. B. Lentsch. 2003. Cytokine cascades and the hepatic inflammatory response to ischemia and reperfusion. J. Invest Surg. 16: 141-147.
48. Serracino-Inglott, F., N. A. Habib, and R. T. Mathie. 2001. Hepatic ischemia-reperfusion injury. Am. J. Surg. 181: 160-166.
49. Teoh, N. C., and G. C. Farrell. 2003. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J. Gastroenterol. Hepatol. 18: 891-902.